Chemours Reports Executive Changes and Compensation Arrangements

Ticker: CC · Form: 8-K · Filed: 2024-02-16T00:00:00.000Z

Sentiment: neutral

Topics: executive-changes, compensatory-arrangements, corporate-governance

TL;DR

**Chemours just filed an 8-K about executive changes and compensation, keep an eye out for details!**

AI Summary

The Chemours Company filed an 8-K on February 16, 2024, reporting an event that occurred on February 12, 2024. The filing pertains to Item 5.02, "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers," and Item 9.01, "Financial Statements and Exhibits." This indicates changes in executive leadership or their compensation, though specific names or dollar amounts are not detailed in the provided text.

Why It Matters

Changes in executive leadership or their compensation can signal strategic shifts, financial performance issues, or new directions for a company, directly impacting investor confidence and future stock performance.

Risk Assessment

Risk Level: medium — The filing indicates changes in leadership or compensation, which can introduce uncertainty or signal underlying issues without further details.

Key Players & Entities

FAQ

What is the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on February 12, 2024.

Which items are reported in this 8-K filing?

This 8-K filing reports on Item 5.02, "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers," and Item 9.01, "Financial Statements and Exhibits."

What is the full legal name of the registrant?

The exact name of the registrant as specified in its charter is The Chemours Company.

What is the business address of The Chemours Company?

The business address of The Chemours Company is 1007 Market Street, Wilmington, Delaware 19801.

When was this 8-K filed with the SEC?

This 8-K was filed with the SEC on February 16, 2024.

From the Filing

0000950170-24-016376.txt : 20240216 0000950170-24-016376.hdr.sgml : 20240216 20240216161611 ACCESSION NUMBER: 0000950170-24-016376 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240212 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 24648559 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 cc-20240212.htm 8-K 8-K false 0001627223 0001627223 2024-02-12 2024-02-12     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   February 12, 2024 Date of Report (Date of Earliest Event Reported)   The Chemours Company (Exact Name of Registrant as Specified in Its Charter)   Delaware   001-36794   46-4845564 (State or Other Jurisdiction   (Commission   (I.R.S. Employer Of Incorporation)   File Number)   Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices)   Registrant’s telephone number, including area code: (302) 773-1000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐         Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On February 12, 2024, Sandra P. Rogers notified the Board of Directors (the “Board”) of The Chemours Company (the “Company”) of her decision not to seek re-election to the Board at the Company’s 2024 Annual Meeting of Stockholders, when her current term expires. Ms. Rogers’ decision is not a result of any disagreement regarding the Company’s operations, policies, or practices.   On February 13, 2

View on Read The Filing